Meghmani Organics Q1 FY27 Net Profit Surges 42% YoY to ₹57.6 Crore
Meghmani Organics reported Q1 FY27 standalone results with revenue at ₹522.9 crore, down 12% YoY. Net Profit surged 42% YoY to ₹57.6 crore, and EBITDA grew 16% YoY to ₹93.7 crore. Crop Protection was 75% of revenue, while Pigments were 25%. TiO2 operations remain suspended.
The strong profit growth is a positive indicator for the company's financial health, but the YoY revenue decline and suspended TiO2 operations suggest potential headwinds.
Despite a YoY revenue decline, the company achieved a significant YoY growth in Net Profit and EBITDA, indicating strong operational efficiency and pricing power.
Meghmani Organics Limited (MOL) announced its financial results for the first quarter ended June 30, 2026 (Q1 FY27). The company reported standalone revenue from operations at ₹522.9 crore, a decrease of 12% year-on-year, attributed to softer demand amid macroeconomic uncertainties. However, Net Profit for the quarter grew significantly by 42% year-on-year to ₹57.6 crore, driven by better price realization and a favorable product mix. EBITDA also saw a healthy increase of 16% year-on-year, reaching ₹93.7 crore.
The Crop Protection segment accounted for approximately 75% of the company's revenue in Q1 FY27, with revenue and EBITDA standing at ₹391.6 crore and ₹77.8 crore, respectively. The Pigments segment contributed about 25% to the revenue, generating ₹131.3 crore in revenue and ₹15.9 crore in EBITDA.
Mr. Ankit Patel, Chairman & Managing Director, commented on the performance, acknowledging the challenging demand environment and its impact on capacity utilization and revenue. He highlighted the strong improvement in profitability due to better pricing and product mix. The Crop Nutrition segment showed positive contributions, and the company anticipates continued growth momentum, further bolstered by new nano fertilizer products like Nano DAP, Nano NPK, and Nano Zinc.
Operations for Titanium Dioxide (TiO2) remain suspended due to commercial unviability stemming from elevated raw material costs and weaker price realizations following the withdrawal of anti-dumping duty.
What to do with a filing like this
Meghmani Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Meghmani Organics Limited. Read the original for the full detail.